Insights into mechanisms responsible for mesangial alterations associated with fibrogenic glomerulopathic light chains

Nephron

Volumn 94, Issue 2, 2003, Pages

  Teng, Jiamin ^a   Zhang, Ping L ^a   Russell, William J ^a   Zheng, Lu P ^a   Jones, M Lamar ^a   Herrera, Guillermo A ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Fibronectin; Glucose regulated protein; Light chains; Mesangial cells; Transforming growth factor ; Tunicamycin

Indexed keywords

BREFELDIN A; FIBRONECTIN; GLUCOSE REGULATED PROTEIN; ISOPROTEIN; PLATELET DERIVED GROWTH FACTOR B; SCLEROPROTEIN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA; TUNICAMYCIN; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY;

ARTICLE; CELL PROLIFERATION; CELL VACUOLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; EXPOSURE; GLOMERULOPATHY; GLYCOSYLATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; HUMAN TISSUE; MESANGIUM CELL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; UPREGULATION; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; GLOMERULUS; IMMUNOLOGY; KIDNEY TUBULE; MESANGIUM; PATHOLOGY; URINE;

ANTIBODIES, MONOCLONAL; BREFELDIN A; CELL DIVISION; CELLS, CULTURED; FIBRONECTINS; GLOMERULAR MESANGIUM; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; KIDNEY GLOMERULUS; KIDNEY TUBULES; PROTO-ONCOGENE PROTEINS C-SIS; TRANSFORMING GROWTH FACTOR BETA; TUNICAMYCIN;

EID: 0346014854     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071288     Document Type: Article

References (25)

1. Gallo G, Picken M, Buxbaum J, Frangione B: The spectrum of monoclonal immunoglobulin deposition disease associated with immunocytic dyscrasias. Semin Hematol 1989:26:234-245.
2. Sanders PW, Herrera GA, Kirk KA, Old CW, Galla JH: Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition. Lab Invest 1991:64:527-537.
3. Herrera GA: Renal manifestations in plasma cell dyscrasias: An appraisal from the patients' bedside to the research laboratory. Ann Diagn Pathol 2000:4:174-200.
4. Herrera GA, Russell WJ, Isaac J, Turbat-Herrera EA, Tagouri Y, Sanders PW, Dempsey S: Glomerulopathic light chain - mesangial cell interactions modulate in vitro extracellular matrix remodeling and reproduce mesangiopathic findings documented in vivo. Ultrastruct Pathol 1999:23:107-126.
5. Zhu L, Herrera GA, Murphy-Ullrich JE, Huang Z-Q, Sanders PW: Pathogenesis of glomerulosclerosis in light chain deposition disease: Role for transforming growth factor-β. Am J Pathol 1995:147:375-385.
6. Herrera GA, Shultz MS, Soong SJ, Sanders PW: Growth factors in monoclonal light-chain-related renal disease. Hum Pathol 1994:25: 883-892.
7. Kuznetsov G, Nigam SK: Folding of secretory and membrane proteins. N Engl J Med 1998: 339:1688-1695.
8. Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J: Protein sorting: Organelle biogenesis and protein secretion; in Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J (eds): Molecular Cell Biology, ed 4. New York, Freeman, 1999, pp 675-750.
9. Kuznetsov G, Bush KT, Zhang PL, Nigam SK: Perturbations in maturation of secretory proteins and their association with endoplasmic reticulum chaperones in a cell culture model for epithelial ischemia. Proc Natl Acad Sci USA 1996:93:8584-8589.
10. Harper PA, Robinson JM, Hoover RL, Wright TC, Karaovsky MC: Improved methods for cultured rat glomerular cell. Kidney Int 1984: 26:875-880.
11. Sanders PW, Herrera GA, Galla JH: Human Bence Jones protein toxicity in rat proximal tubule epithelium in vivo. Kidney Int 1987:32: 851-861.
12. Russell JW, Cardelli J, Harris E, Baier RJ, Herrera GA: Monoclonal light chain-mesangial cell interactions: Early signaling events and subsequent pathologic effects. Lab Invest 2001:81: 689-703.
13. Elbein AD: The tunicamycins - Useful tools for studies on glycoproteins. Trends Biochem Sci 1981:6:219-221.
14. Li M, Baumeister P, Roy B, Phan T, Foti D, Luo S, Lee AS: ATF6 as a transcription activator of the endoplasmic reticulum stress element: Thapsigargin stress-induced changes and synergistic interactions with NF-Y and YY1. Mol Cell Biol 2000:20:5096-5106.
15. Parker R, Phan T, Baumeister P, Roy B, Cheriyath V, Roy AL, Lee AS: Identification of TFII-I as the endoplasmic reticulum stress response element binding factor ERSF: Its auto-regulation by stress and interaction with ATF6. Mol Cell Biol 2001;21:3220-3233.
16. Brodsky JL, Werner ED, Dubas ME, Goeckeler JL, Kruse KB, McCracken AA: The requirement for molecular chaperones during endoplasmic reticulum- associated protein degradation demonstrates that protein export and import are mechanistically distinct. J Biol Chem 1999:272:20427-20434.
17. Ellgaard L, Molinari M, Helenius A: Setting the standards: Quality control in the secretory pathway. Science 1999:286:1882-1888.
18. Grewal JS, Mukhin YV, Garnovskaya MN: Serotonin 5-HT2A receptor induces TGF-β1 expression in mesangial cells via ERK: Proliferative and fibrotic signals. Am J Physiol 1999: 276:F922-F930.
19. Poncelet A, Schnaper HW: Regulation of human mesangial cell collagen expression by transforming growth factor-β1. Am J Physiol 1998:275:F458-F466.
20. Heldin C, Miyazono K, ten Dijke P: TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 1997:390:465-471.
21. Massague J: TGF-β signaling: Receptors, transducers, and Mad proteins. Cell 1996:85:947-950.
22. Throckmorton DC, Brogden AP, Min B, Rasmussen H, Kashgarian M: PDGF-β and TGF-β mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney Int 1995:48:111-117.
23. Ostendorf T, Kunter U, Roeyen CV, Dooley S, Janjic N, Ruckman J, Eitner F, Floege J: The effects of platelet-derived growth factor antagonism in experimental glomerulonephritis are independent of the transforming growth factor-β system. J Am Soc Nephrol 2002:13:658-667.
24. Moses HL, Yang EY, Pietenpol JA: TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights. Cell 1990:63:245-247.
25. Laiho M, DeCapiro JA, Ludlow JW, Livingston DM, Massague J: Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 1990:62:175-185.